← Leaderboards
Sean N Tucker
Genteric, Inc.
$5,065,985
Attributed
$5,065,985
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2007–11$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$5,065,985 · 5
By mechanism
R44$2,779,602 · 1
U01$1,246,796 · 1
R43$1,039,587 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vector”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- David Heimbrook · Leidos Biomedical Research, Inc.$141,066,079
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,296,230
- Philip Goode · New Jersey Institute Of Technology$73,697,028
Research focus
VectorOralVaccinationVaccinesImmune ResponseMucous MembraneImmunityTechnologyVaccine EfficacyReceptorAdenovirusesAntigensImmuneMeasurementAdenovirus VectorBaseOral VaccinePathogenLigandsGenesAntibodiesIntestinesAntibody FormationViral
Grant awards (10)
Enhanced Oral Vaccine Delivery Vehicle$975,540
R44 · FY2011 · AI · contact PI
Enhanced Oral Vaccine Delivery Vehicle$850,927
R44 · FY2010 · AI · contact PI
Mucosal Vector with TLR3 agonist for protection against VEE$631,471
U01 · FY2010 · AI · contact PI
Enhanced Oral Vaccine Delivery Vehicle$953,135
R44 · FY2009 · AI · contact PI
Mucosal Vector with TLR3 agonist for protection against VEE$615,325
U01 · FY2009 · AI · contact PI
Recombinant Adenoviral Vector with Encoded TLR3 Ligand for Protection Against VEE$120,993
R43 · FY2009 · AI · contact PI
Enhanced Oral Vaccine Delivery Vehicle$300,000
R43 · FY2008 · AI · contact PI
Recombinant Adenoviral Vector with Encoded TLR3 Ligand for Protection Against VEE$219,512
R43 · FY2008 · AI · contact PI
Enhanced Oral Vaccine Delivery Vehicle$299,082
R43 · FY2007 · AI · contact PI
Genetic vaccination through salivary gland transduction$100,000
R43 · FY2002 · DE